Jean‐Luc Raoul
Centre Eugène Marquis
2 papers in the Anchorcite directory, published between 2008 and 2011, cited 21,225 times in total.
ORCID profileResearch topics
- Colorectal Cancer Treatments and Studies · 1 paper
- Hepatocellular Carcinoma Treatment and Prognosis · 1 paper
- Renal cell carcinoma treatment · 1 paper
- Cancer Treatment and Pharmacology · 1 paper
- Pancreatic and Hepatic Oncology Research · 1 paper
- Pancreatitis Pathology and Treatment · 1 paper
Frequent co-authors
- Josep Maria Llovet · 1 paper
- Sergio Ricci · 1 paper
- Vincenzo Mazzaferro · 1 paper
- Philip a. Hilgard · 1 paper
- Edward John Gane · 1 paper
- Jean Frédéric Blanc · 1 paper
- André Cosme de Oliveira · 1 paper
- Armando Santoro · 1 paper
Papers
- Sorafenib in Advanced Hepatocellular CarcinomaNew England Journal of Medicine · 2008 · 13,250 citations
BACKGROUND: No effective systemic therapy exists for patients with advanced hepatocellular carcinoma. A preliminary study suggested that sorafenib, an oral multikinase inhibitor of the vascular endothelial growth factor receptor, the platelet-derived growth factor receptor, and Raf may be effective in…
- FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic CancerNew England Journal of Medicine · 2011 · 7,975 citations
BACKGROUND: Data are lacking on the efficacy and safety of a combination chemotherapy regimen consisting of oxaliplatin, irinotecan, fluorouracil, and leucovorin (FOLFIRINOX) as compared with gemcitabine as first-line therapy in patients with metastatic pancreatic cancer. METHODS: We randomly assigned 342…
Metadata from OpenAlex (CC0).